StonvexLoading…
StonvexStonvexStonvexCore line items from NWN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $279.57M | $460.60M | $1.21B | $848.60M | $694.20M |
Operating Income | Not available | $162.87M | $280.89M | $169.14M | $181.56M |
Net Income | Not available | $97.49M | $113.32M | $55.53M | $85.42M |
EPS (Diluted) | $-0.06 | $2.33 | $2.77 | $1.36 | $2.11 |
Total Assets | Not available | $6.42B | $6.17B | $5.85B | $5.79B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $34.95M | $36.67M | $32.20M | $102.58M |
Free Cash Flow OCF − CapEx | Not available | $2.47M | $-197.77M | $-66.80M | $59.11M |
Shares Outstanding | Not available | 42.08M | 41.56M | 41.51M | 40.91M |